|
J Biol Chem, Vol. 275, Issue 5, 3335-3342, February 4, 2000
Parathyroid Hormone-activated Volume-sensitive Calcium Influx
Pathways in Mechanically Loaded Osteocytes*
Akimitsu
Miyauchiabc,
Kohei
Notoyad,
Yuko
Mikuni-Takagakie,
Yasuyuki
Takagiab,
Masayuki
Gotod,
Yoshiki
Mikif,
Teruko
Takano-Yamamotog,
Kenji
Jinnaia,
Keiichi
Takahashia,
Masayoshi
Kumegawah,
Kazuo
Chiharab, and
Takuo
Fujitai
From the a National Sanatorium Hyogo Chuo Hospital, Sanda,
Hyogo 669-1515, d Pharmaceutical Research Division, Takeda
Chemical Industries Limited, Yodogawa-ku, Osaka 532-8686, e Department of Oral Biochemistry, Kanagawa Dental College,
Yokosuka 238-8580, f Department of Orthodontics, Tokushima
University Dental School, Tokushima 770-0042, g Department of
Orthodontics, Okayama University Dental School, Shikatacho,
Okayama 700-8525, h First Department of Oral Anatomy, Meikai
University School of Dentistry, Sakado, Saitama 350-0248, b Third Division, Department of Medicine, Kobe University School
of Medicine, Kobe 650-0017, and i Calcium Research Institute,
Kishiwada 596-0842, Japan
 |
ABSTRACT |
This paper documents for the first time a
volume-sensitive Ca2+ influx pathway in osteocytes,
which transmits loading-induced signals into bone formation. Stretch
loading by swelling rat and chicken osteocytes in hypo-osmotic solution
induced a rapid and progressive increase of cytosolic calcium
concentration, [Ca2+]i. The influx of
extracellular Ca2+ explains the increased
[Ca2+]i that paralleled the increase in the mean
cell volume. Gadolinium chloride (Gd3+), an inhibitor of
stretch- activated cation channels, blocked the
[Ca2+]i increase caused by hypotonic solutions.
Also, the expression of 1C subunit of voltage-operated
L-type Ca2+ channels ( 1C) is required for
the hypotonicity-induced [Ca2+]i increase judging
from the effect of 1C antisense oligodeoxynucleotides. Parathyroid
hormone (PTH) specifically potentiated the hypotonicity-induced
[Ca2+]i increase in a dose-dependent
manner through the activation of adenyl cyclase. The increases induced
by both PTH and hypotonicity were observed primarily in the processes
of the osteocytes. In cyclically stretched osteocytes on
flexible-bottomed plates, PTH also synergistically elevated the
insulin-like growth factor-1 mRNA level. Furthermore,
Gd3+ and 1C antisense significantly inhibited the
stretch-induced insulin-like growth factor-1 mRNA elevation. The
volume-sensitive calcium influx pathways of osteocytes represent a
mechanism by which PTH potentiates mechanical responsiveness, an
important aspect of bone formation.
 |
INTRODUCTION |
Mechanical loading applied to the skeleton has been shown to cause
osteotropic influences. On the other hand, prolonged immobilization is
one of the important reasons of bone loss. However, the intracellular mechanisms by which bone cells sense mechanical strain are not well
known (1).
Although osteocytes are the most abundant cells in bone, the role of
osteocytes in bone remodeling was not clear until recently. Direct
inhibition of osteoclastic activity by osteocyte-derived protein
through osteoclast-osteocyte attachment was demonstrated (2, 3).
Furthermore, intermittent mechanical loading within the physiological
range enhances IGF-11
mRNA expression in osteocytes (4, 5), suggesting that these cells
transduce signals induced by mechanical stress to osteoblasts. Although
various other mediators such as prostaglandins (6-8), cyclooxygenase-2
(encoding prostaglandin G/H synthase), (8, 9), endothelial,
constitutive nitric oxide synthase (10), or c-fos (8,
11-13) have been suggested, the exact mechanosensing mechanisms in
these cells are not clear. Although the involvement of
stretch-activated cation channels (SA-Cat) in the reception of
mechanical stress has been reported in many other cell types, none has
been functionally demonstrated in osteocytes so far.
The localization of PTH receptors by in situ hybridization
(14), as well as the synergistic effects of mechanical stress and PTH
(13, 15), on the other hand, indicated the important role of PTH in
regulating the signal transduction of mechanical stress in osteocytes.
Stretch-activated cation channels and their activation by PTH were
demonstrated in UMR 106 osteoblast-like cells by Duncan et
al. (16-18) who suggested either the expression of isoforms of
the 1C subunit of the voltage-operated Ca24 channel
(VOCC) is required for the activity or that the channel may have
homology to the 1C subunit of VOCC. Osteocytes differentiate from
osteoblasts along with a dramatic elongation of cytoplasmic processes.
This morphological change suggests that their levels of sensitivity to
mechanical loading and the mechanisms of response could be distinct.
In this study, we have identified a stretch-activated Ca2+
entry pathway for the first time in both rat and chicken osteocytes by
swelling the cells with hypo-osmotic stress. Also, by using single cell
[Ca2+]i video-image analysis, we demonstrated
that osteocyte processes are furnished with volume-sensitive,
stretch-activated Ca2+ entry pathways that are activated by
PTH. Apparently, the pathways are dependent on the expression of
1C subunit of the VOCC molecule.
 |
EXPERIMENTAL PROCEDURES |
Materials
Fetal calf serum was purchased from Life Technologies, Inc.
Bacterial collagenase was purchased from Wako Biochemicals (Osaka, Japan). The acetoxymethyl ester of fura-2 (fura-2 AM) was purchased from Dojin (Kumamoto, Japan). Parathyroid hormone and its fragments were from Peptide Institute (Osaka, Japan). All other reagents were of
analytical grade from Sigma unless otherwise mentioned.
Osteocytes Culture
Chicken Osteocytes--
Chicken osteocytes were isolated from
bone marrow-free calvariae of 16-day-old chicken embryos according to
the modified method of Van der Plas and co-workers (2, 19).
Briefly, calvariae of 16-day-old chicken embryos were minced and
digested with 1 mg/ml type I collagenase in the isolation buffer (25 mM Hepes, 10 mM NaHCO3, 100 mM NaCl, 3 mM K2HPO4, 1 mM CaCl2, 30 mM KCl, 1 mg/ml bovine
serum albumin, 5 mg/ml glucose, 7.5 µM
-tosyl-L-lysyl chloromethane, a protease inhibitor)
(37 °C, 30 min), washed in PBS, incubated in PBS( ) containing 5 mM EDTA (37 °C, 30 min), and finally digested with
collagenase in the isolation buffer (37 °C, 30 min) and cultured on
glass coverslips in -minimal essential medium with 2% chicken
serum. Most osteocytes were positively stained with osteocyte-specific
monoclonal antibody, OB7.3, kindly provided by Dr. M. J. Alblas
and P. Nijweide (University of Leiden, Netherlands).
Rat Osteocytes--
Rat osteocytes were prepared from frontal
and parietal bones that were dissected aseptically from newborn rats
according to the method of Mikuni-Takagaki et al. (5) with
some modifications. Briefly, pieces of bone were stripped of periosteal
soft tissue and sutures and digested with 25 ml of 0.75 mg/ml
collagenase. Cells released after the first 30 min and the second
through the fourth 20-min digestion at 37 °C (fractions I-IV) were
collected and, filtered through a nylon screen with 40-µm pores, and
the fraction III cells were cultured as osteoblasts at the original density of 5 × 104 cells/ml on glass coverslips
coated with type I collagen. The residual bone pieces were further
washed with 4 mM EDTA in
Ca2+,Mg2+-free PBS and then digested with
collagenase as before for 20 min each. Isolated 2 × 104 fraction VI cells were cultured as young osteocytes on
glass coverslips in Dulbecco's modified Eagle's medium with 10%
fetal calf serum and insulin, transferrin, and selenium. Fraction VI cells were cultured on coverslips coated with Matrigel (Collaborative Biomedical Products/Becton Dickinson Labware, Bedford, MA) to stimulate
cell differentiation toward the osteocytic phenotype (20).
Measurement of Cell Volume
The mean cell volume of rat osteocytes at various osmolarities
was measured using a Coulter counter (CDA-500, Sysmex Co., Kobe, Japan)
adapted with a 100-µm diameter aperture as described previously (21,
22). Fraction VI rat young osteocytes (1 × 104) were
resuspended in various Ringer's solutions of different osmolarities,
and the cell volume was measured. Cell volume distribution curve was
taken, and mean cell volume was calculated by computer software.
Measurement of Cytosolic Calcium, [Ca2+]i,
and [Ca2+]i Imaging in Hypotonically
Stretched Cells
Cytosolic calcium was measured in single cells using the
fluorescent calcium indicator, fura-2 as described previously (23-25). Osteocytes cultured for 1-2 days on glass coverslips were washed with
PBS and loaded with 5 µm fura 2/AM for 1 h at 25 °C in
Ringer's solution (138 mM NaCl, 5.5 mM KCl, 1 mM MgCl2, 1 mM CaCl2,
and 20 mM Hepes buffer (pH 7.3 with NaOH)). After two
washes with Ringer's solution, the measuring chamber was mounted to a
microfluorometric system and images (F340 and F360) were collected at
wavelengths of 340 and 360 nm. The ratio of F340/F360 constructed after
background image subtraction disclosed subcellular
[Ca2+]i localization. The average cell
[Ca2+]i values were calculated from calibration
curve as described (26, 27).
Stretching Procedures on Flexible-bottom Plates--
Rat osteocytes cultured on Matrigel were placed 5-7 mm from the
edge of the flexible plate wells coated with type I collagen (5, 8).
For stretching at the physiological level, the bottom of the plate was
deformed by a computer operated vacuum system (Flexercell Strain Unit,
Flexercell Corp., McKeesport, PA), with a frequency of 1/2.5 Hz (4 cycles of stretching in 10 s, followed by 50 s of relaxation)
for 1 h. The expected strain was between 2,000 µE (microstrain)
and 4,000 µE (0.4% elongation).
Introduction of Oligodeoxynucleotides
A pair of antisense/sense oligodeoxynucleotides (ODNs) of 24- and a 20-mer antisense ODN were developed from the sequence of 1C
cDNA of the L-type calcium channel genes isolated from the UMR 106.01 cells (28). The sequence of the antisense ODN (24-mer)
was 5'-CCTTCCGTGCTGTTGCTGGGCTCA-3' and the sense ODN was
5'-TGAGCCCAGCAACAGCACGGAAGG-3'. The sequence of the antisense 20-mer
was ACTCTGGAGCACACTTCTTG. Cells were first washed with the
permeabilization buffer (137 mM NaCl, 5.6 mM
glucose, 2.7 mM KCl, 2.7 mM EGTA, 1 mM NaATP, 100 mM Pipes, 0.1% bovine serum albumin (pH 7.4)) and then treated with the buffer containing 0.5 unit/ml streptolysin O and the appropriate ODN at 100 µM
for 5 min at room temperature. The incubation was terminated by
replacing the buffer with the normal Dulbecco's modified Eagle's
medium with 10% fetal calf serum. Eighteen hours later, cells were
stretched either by swelling them in the hypotonic solution or by
stretching them on flexible bottom plates. Ca2+ imaging or
RT-PCR analysis of IGF-1 mRNA was performed as described under
"Experimental Procedures." Similar procedures were used for
application of antisense ODNs to the 1S and 1D isoforms of the
1 subunits of the L-type calcium channels (18, 28).
RT-PCR Analysis of IGF-1
Total RNA was extracted from osteocyte cultures and was reverse-
transcribed by random hexamer priming as described previously (8). Each
RT reaction mixture contained 1 µg of total RNA, 50 pmol of random
9-mer, and 200 units of Superscript II reverse transcriptase (Life
Technologies, Inc.) in a total volume of 20 µl. After denaturation of
mRNA at 70 °C for 10 min, the reaction were preincubated for 10 min at 25 °C and incubated at 42 °C for 50 min. Portions were as
follows: 0.2-1 µl of the RT product cDNA were amplified using
Ready To Go PCR Beads (Amersham Pharmacia Biotech) containing ~1.5
units of Taq DNA polymerase. Sense and antisense primers
(12.5 pmol) were added, and the reaction was carried out in 27 cycles
for IGF-1 and 18 cycles for GAPDH, denaturation at 94 °C for 3 min,
followed by set cycles of 30 s at 94 °C for denaturation;
30 s at 55 °C for annealing; and 1 min at 72 °C for
polymerization. Primers used are as follows: IGF-1,
5'-GCATTGTGGATGAGTGTTGC and 3'-GGCTCCTCCTACATTCTGTA; GAPDH, 5'-
GCCATCAACGCCCCTTCATTGAC and 3'- ACGGAAGGCCATGCCAGTGAGCTT (8).
For the quantitative real-time PCR analysis of IGF-1 mRNA
levels, LightCyclerTM System and reagents (Roche Molecular
Biochemicals) were used with a double strand DNA binding dye, SYBR
Green I, according to the procedure provided by the manufacturer. Up to
40 cycles at 95 °C exposure, annealing for 10 s, and extension
at 72 °C for 13 s were repeated.
RT-PCR Analysis of the L-type VOCC 1 Subunit in Rat
Osteocytes
The PCR primers are oligodeoxynucleotides of 25 and 26 base
pairs (bp) designed to amplify 903-bp fragments (29). PCR was carried
out for 28 cycles after 2 min denaturation at 94 °C as follows:
30 s at 94 °C for denaturation; 30 s at 56 °C for
annealing; and 4 min at 72 °C for polymerization. The amplimers were
separated by electrophoresis through 3% agarose gels in Tris borate buffer.
Statistical Analysis
Statistical comparisons were made by one-way analysis of
variance. When significant effects were observed, Dunnett's test was
used for multiple comparisons. A p value of less than 0.05 was considered significant.
 |
RESULTS |
Hypotonicity-induced Changes in [Ca2+]i of
Cultured Osteocytes--
The basal values of
[Ca2+]i were not significantly different between
rat young osteocytes (170 ± 7 nM, mean ± S.E., n = 167) and highly purified chicken osteocytes
(133 ± 13 nM, mean ± S.E., n = 26). Hypotonic challenge was performed by replacing media by various
low Na+ Ringer solutions as described previously in UMR 106 cells (17, 18). Cell swelling due to the replacement of the bathing
media with hypotonic Ringer's solution (65 mM NaCl, 182 mosm) caused a rapid and sustained increase of
[Ca2+]i in both rat (Fig.
1A) and chicken osteocytes
(Fig. 1E). The duration of hypotonicity-stimulated
[Ca2+]i increase varied among cells. The net
increase in [Ca2+]i was dependent on the change
in osmolarities as shown in Fig. 2.
Hypotonicity-induced [Ca2+]i increase was
similarly observed by using mannitol instead of the Ringer's solution
with different Na+ concentrations to change osmolarities,
suggesting that the [Ca2+]i increase observed
here is not an artifact due to Na+ decrease.
Hypotonically-induced increases in both [Ca2+]i
and mean cell volumes at different osmolarities are plotted in Fig. 2.
When cells in suspension were exposed to Ringer's solutions of lower
osmolarity, mean cell volume increased linearly up to 2.61-fold at 106 mosm solution. Both the increase in the mean cell volume measured in
cell suspension and the increase in [Ca2+]i,
which was measured in single attached cells on glass coverslips, showed
linear relationships to the change of osmolarity. Even when the mean
cell volume increased only 23%, the [Ca2+]i
increase of 21 ± 5 nM (n = 10) was
detectable. Thus, the [Ca2+]i increase correlates
well with the changes in cell volume.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of hypotonic replacement on
[Ca2+]i of single rat osteocyte
(A-D) and chicken osteocyte (E and
F). Rat or chicken osteocytes were grown on glass
coverslips for 1-2 days. Cells were then loaded with fura-2, and
[Ca2+]i of single cells was measured as described
under "Experimental Procedures." A, this shows the rapid
and progressive increase in [Ca2+]i in a rat
osteocyte exposed to hypotonic Ringer's solution (182 mosm). Peak
[Ca2+]i increases from basal in rat osteocytes
were 100 ± 15 nM (S.E.) (n = 16).
B, a selective inhibitor of stretch-activated cation
channels, Gd3+ (2 × 10 5 M),
blocked the [Ca2+]i increase in response to
hypotonic stimulus in a rat osteocyte. D, an inhibitor of
intracellular Ca2+ store refilling, thapsigargin (2.5 µM), was added to the bathing medium before hypotonic
stimulus. Hypotonicity-stimulated [Ca2+]i
increase was also observed in the presence of thapsigargin.
E, the rapid and progressive increase in
[Ca2+]i exposed to hypotonic Ringer's solution
(182 mosm) was also observed in a cultured chicken osteocyte. Peak
[Ca2+]i increases from basal in chicken
osteocytes were 110 ± 17 nM (S.E.) (n = 8). C and F, under nominally Ca2+
free conditions with 4 mM EGTA hypotonic stimulus did not
affect [Ca2+]i of a single chicken (F)
as well as rat (C) osteocyte. Tracings are
representative of at least three experiments for each condition.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Dose-response relationship of
hypotonicity-induced [Ca2+]i increase from base
line in rat osteocytes compared with relative cell volume. Peak
values of increase in [Ca2+]i in rat osteocytes
exposed to various hypotonic Ringer's solutions (106-307 mosm, normal
363 mosm) were plotted. The numbers of cells from several sets of
experiments are shown in parentheses. In addition, the peak
values of mean cell volume of suspended cells exposed to various
hypotonic Ringer's solutions were plotted. Mean cell volume, 967.7 µm3 of 1.26 × 104 cells in normal
Ringer's solution (363 mosm) is the control value. To decrease
osmolarity, the concentration of NaCl in the medium was reduced.
Osmolarity was measured by an osmometer. Data are expressed as
means ± S.E. The increases in cytosolic calcium measured at
106-250 mosm were significant (p < 0.001 to
p < 0.05).
|
|
Under nominally Ca2+-free conditions after replacing the
medium with Ca2+-free Ringer's solution containing 4 mM EGTA, hypotonic treatment did not affect
[Ca2+]i in either rat or chicken osteocytes (Fig.
1, C and F). Also pretreatment of the cells with
2.5 µM thapsigargin, an inhibitor of intracellular
Ca2+ store refilling (30), caused a gradual
[Ca2+]i increase due to the release from the
internal Ca2+ stores but did not affect the peak level of
hypotonicity-induced [Ca2+]i increase (Fig.
1D), suggesting that the influx of extracellular
Ca2+ is primarily responsible for the hypotonically induced
increase in [Ca2+]i. In contrast, the
[Ca2+]i increase was inhibited by 80% by an
inhibitor of the stretch-activated cation channel, Gd3+
(Fig. 1B) (31). Further experiments using antagonists of
VOCC, nitrendipine (10 6 M), verapamil (50 µM) showed partial inhibition in hypotonicity-stimulated Ca2+ increases (data not shown except that with
nitrendipine appearing later in Fig. 6). Micromolar concentrations of
these Ca2+ channel antagonists were required for
significant inhibition of the volume-sensitive Ca2+ influx pathway.
Involvement of 1C Subunit VOCC--
In UMR 106.01 cells, it was
demonstrated by Duncan et al. (18) that antisense
oligodeoxynucleotides, ODNs, derived from the sequence of 1C subunit
of voltage-operated calcium channels, abolished the whole-cell
conductance (Gm) induced by hypotonic swelling. Therefore,
we first examined the expression of 1C subunit by RT-PCR according
to Meszaros et al. (29). As shown in Fig. 3, all three sets of primers they
reported, PR1/2, PR11/12, and 2514/2759, gave us amplimers of the
reported sizes (903, 740, and 245 bp) in rat osteocytes. Then we tested
whether antisense ODNs (24- and 20-mer), directed to IVS6 region of the
1C subunit, have any effects on the hypotonicity-stimulated
[Ca2+]i increase observed in rat osteocytes.
Antisense ODNs (24- and 20-mer) against the 1C subunit blocked the
[Ca2+]i increase by >80% (Fig.
4 and Table
I). Neither antisense ODNs against the
same IVS6 region in the 1S nor 1D subunit affected the hypotonic
stimulation of [Ca2+]i. The introduction of these
ODNs did not inhibit cell viability as observed by trypan blue
exclusion. The volume-sensitive stretch-activated Ca2+
entry pathways in osteocytes, therefore, are dependent on the 1C
subunit of VOCC or a closely related molecule, as was previously shown
in UMR 106.01 cells (18).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 3.
Expression of 1C
subunit of VOCC in rat osteocytes. Expression of 1C subunit was
demonstrated by RT-PCR using three sets of primers: 2514/2759
(left, 3rd lane), PR11/12 (right, 1st lane), and
PR1/2 (right, 3rd lane) (Meszaros et al. (29)).
Note the reported sizes of amplimers: 245, 740, and 903 bp. Sizes of
GAPDH (left, 1st lane); 609 bp. Std, size markers
(left and right, 2nd lane).
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of sense (24-mer) and antisense
oligodeoxynucleotides (20- and 24-mer) from the
1C subunit of the rat osteocyte calcium channel on
the [Ca2+]i increase after hypotonic
challenges. Cells were loaded with sense or antisense
oligodeoxynucleotides 18 h prior to the experiments. Data are
representative of several similar experiments (see Table I).
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Effect of various ODN on hypotonicity-induced
[Ca2+]i increase in rat osteocytes
Rat osteocytes were incubated at 37 °C for 18 h after the
treatment with various oligodeoxynucleotides (Sham: no ODN,
streptolysin O treatment only) as described under "Experimental
Procedures." Data are expressed as means ± S.E. Number of
experiments is in parentheses.
|
|
Potentiation of the Volume-sensitive Calcium Influx Pathway by PTH
Involves Activation of Adenyl Cyclase--
As shown in Figs.
5 and 6,
10 8 to 10 6 M PTH-(1-34)
enhanced the hypotonicity-induced [Ca2+]i
increase up to 2.2-fold in a dose-dependent manner. To
determine whether activation of adenylate cyclase is required for
stimulation of volume-sensitive calcium influx pathway by PTH, we
compared the effects of fully active PTH-(1-34), PTH-(1-31), a
selective agonist that activates adenyl cyclase but not phospholipase C
(32), and PTH-(3-34), a selective agonist that activates phospholipase C but not adenyl cyclase (33). PTH-(1-31) had a comparable effect on
hypotonicity-induced [Ca2+]i increase, whereas
PTH-(3-34) showed no such effect. Next we studied the diastereoisomers
of the phosphorothioate analogue of cAMP,
(Sp)-cAMP, a selective stimulator of protein
kinase A, and (Rp)-cAMP, a selective inhibitor
(34, 35). As expected, (Sp)-cAMP had a
stimulatory effect on hypotonicity-induced
[Ca2+]i increase similar to PTH-(1-34), whereas
(Rp)-cAMP was inhibitory (Fig. 6). Other
substances such as dibutyryl cAMP (10 3 M) and
forskolin (10 5 M), which activate adenyl
cyclase signal transduction pathways, also stimulated
hypotonicity-induced [Ca2+]i increases. On the
contrary, TPA (10 7 M) which activates protein
kinase C signaling had no effect on hypotonicity-induced
[Ca2+]i increase (Figs. 5 and 6). Adenyl cyclase
signal transduction pathway seems to be required for stimulation of
hypotonicity-induced [Ca2+]i increases.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of various substances on
hypotonicity-induced [Ca2+]i increase in single
rat osteocytes. Cell preparations and
[Ca2+]i measurements were performed as described
under "Experimental Procedures." A, effect of hypotonic
replacement (363 to 182 mosm) on [Ca2+]i shown as
control (same as Fig. 1A). B, effect of
PTH-(1-34) (10 7 M). C,
PTH-(1-31) (10 7 M). D, dibutyryl
cAMP (DbcAMP, 10 3 M).
E, TPA (10 7 M). F,
PTHrp-(1-34) (10 7 M). Test substance was
added to the bathing medium before hypotonic stimulation. Concentration
of these substances was kept constant during experiments.
Tracings are representative of at least four experiments for
each condition (see Fig. 6).
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of various agents on
hypotonicity-induced [Ca2+]i increase in rat
osteocytes. Experiments were performed as described in Figs. 1 and
5. Rat osteocytes were challenged with hypotonic replacement of buffer
(363 to 182 mosm) after incubations with various agents or control
vehicle shown here for 3 to 5 min if not specified.
[Ca2+]i was measured as described under
"Experimental Procedures." Data are expressed as the amplitude of
the effect of hypotonic replacement (363 to 182 mosm) on
[Ca2+]i in the presence of various substances,
normalized to the response obtained in the presence of vehicle only.
Means ± S.E. Number of experiments is in parentheses.
*, p < 0.05 versus control (vehicle only
treated); **, p < 0.01 versus control, ***,
p < 0.001 versus control. The control
values in vehicle only treated groups are 100 ± 15 nM
(n = 16) (vehicle H2O, 0.1%) and 108 ± 12 nM (n = 27) (vehicle EtOH,
0.1%).
|
|
PTH Potentiation of the Volume-sensitive Calcium Influx Pathway,
Demonstrated by [Ca2+]i Imaging--
Next the
relationship between PTH-induced and hypotonically induced
[Ca2+]i changes was investigated by
Ca2+ imaging (Fig. 7). Rat
young osteocyte with extended cell processes exhibited relatively
homogeneous basal subcellular [Ca2+]i
localization (Fig. 7B). Ten to 20 s (Fig. 7,
C and D) after adding 10 8
M PTH, higher submembranous Ca2+ concentration
(yellow to red) appeared both in the cell
processes and cell bodies resulting in dense localization in the cell
processes. A very similar pattern in the subcellular
[Ca2+]i changes was observed after the hypotonic
challenge (within 10-20 s, Fig. 7, F and G),
supporting the notion that hypotonically induced cell swelling as well
as PTH administration resulted in the Ca2+ influx into the
osteocytes.

View larger version (96K):
[in this window]
[in a new window]
|
Fig. 7.
Digital image analysis of
[Ca2+]i in single fura-2 loaded rat osteocytes
during exposure to PTH-(1-34) (10 8
M) and hypotonic Ringer's solution (182 mosm).
A, phase contrast image. An isolated rat osteocyte with long
processes is visible. B, basal 340/360 nm ratio image,
converted to [Ca2+]i. C-E, sequence
of images taken 10, 20, and 120 s after the addition of
10 8 M PTH. F and G,
sequence images taken 10 and 20 s after the replacement of
hypotonic Ringer's solution (182 mosm) in the presence of PTH. The
ratio color scale, converted to [Ca2+]i as
described under "Experimental Procedures", is shown on the
right of the figure.
|
|
The images of the cell in Fig. 7 were further analyzed by averaging the
[Ca2+]i values of the pixels (2 × 2) within
three different areas, as indicated in Fig.
8. The resulting composite time-based plot is shown in Fig. 8 (Fig. 7A, cell process
(1), submembranous region of the cell body (2),
and perinuclear cytoplasm (3)). PTH-(1-34) (10 8 M) induced a transient increase in
[Ca2+]i (100 nM above basal). The
largest and fastest [Ca2+]i increase by both PTH
and hypotonic stimulus was observed in the cytosolic processes (Fig. 8)
compared with the other areas.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 8.
Time-based plot of the experiment illustrated
in Fig. 7. [Ca2+]i was averaged within three
different subcellular areas (2 × 2 pixels) indicated in Fig.
7A at different time points during stimulation with PTH and
hypotonic Ringer's solution (182 mosm).
|
|
Synergistic Up-regulation of IGF-1 mRNA Levels by PTH and
Stretching--
Next we tested whether PTH is involved in the process
of IGF-1 mRNA up-regulation in stretched rat osteocytes. As shown
in Fig. 9, left panel,
stretching the culture support by itself raised the level of IGF-1
mRNA (4th lane versus
1st). One-hour incubation with PTH-(1-34)
dose-dependently up-regulated IGF-1 mRNA levels regardless of the presence (5th and 6th
lanes) or absence (2nd and 3rd
lanes) of stretching.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 9.
Effect of PTH in combination with 1-h
stretching on IGF-1 mRNA expression. Cells were stretched for
1 h either in the presence or absence of PTH-(1-34)
10 8 to 10 7 M), which was added
10 min before the initiation of stretching. Left panel, 1st
lane, no stretch control; 2nd and 3rd
lanes, PTH alone; 4th lane, stretched;
5th and 6th lanes, stretched with PTH;
7th lane, size marker (Std, same as
Fig. 3). Right panel, GAPDH expression under the same
conditions as in left panel shows no apparent changes.
|
|
Elevation of the IGF-1 mRNA Level in Stretched Osteocytes
Involves Activation of the Volume-sensitive Calcium Influx
Pathway--
Fig. 10 shows
semi-quantitative analysis of stretch-induced IGF-1 mRNA
up-regulation in the presence of various substances. Whereas
PTH-(1-34) dose-dependently up-regulated IGF-1 mRNA
levels regardless of the presence or absence of stretching, PTH-(3-34) had no such effect. PTH-(1-31) and dibutyryl cAMP (10 3
M) had an effect comparable to PTH-(1-34) on
stretching-induced IGF-1 mRNA expression. We have also tested
whether the volume-sensitive stretch-activated Ca2+ entry
pathways of rat osteocytes described here is involved in stretch-induced IGF-1 mRNA up-regulation. Gd3+
(10 5 to 2 × 10 5 M, data
not shown except that with 10 5 M
Gd3+) and nitrendipine (10 6 M),
which inhibited Ca2+ increases by hypotonic solution,
inhibited stretch-induced IGF-1 mRNA elevation by 33-60%.
Similarly, antisense ODN (24-mer) against the 1C subunit blocked the
stretch-induced IGF-1 mRNA elevation by 51% (Fig. 10).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 10.
Effect of various agents on IGF-1 mRNA
level in stretched rat osteocytes. Cells were stretched in the
presence of various agents as described in Fig. 9. After an hour of
stretching, cells were harvested, and tRNA was prepared for RT-PCR
experiments with IGF-1 and GAPDH primers. The ratio of IGF-1/GAPDH
amplimers was calculated from PCR results with
LightCyclerTM System and SYBR Green I dye. Data in the
presence of various substances are normalized to the value of vehicle
experiment. Mean ± S.E., n = 3. *,
p < 0.05 versus stretched control
(S); **, p < 0.01 versus
stretched control (S). For the experiments of 1C
antisense ODN (24-mer), cells were loaded with sense or antisense ODNs
18 h prior to the experiments. Data are expressed as the amplitude
of the response in antisense ODN-treated group, normalized to the sense
ODN-treated group; mean ± S.E., n = 3. The value
of antisense ODN-treated group is significantly (p < 0.05) different from sense ODN-treated group although the value of
sense-treated group was variable depending on the experiment.
|
|
 |
DISCUSSION |
Several in vivo and in vitro studies of
osteocytes demonstrated that mechanical stress, either directly applied
on vital bone, by exposing to pulsating fluid flow, or by deformation
of cells plated on silicon membrane, induced rapid responses in
mRNA expression of various genes as described in the Introduction.
This accumulating evidence as well as biomechanical studies suggest
that osteocytes respond to mechanical stress and transmit signals to
other cells in bone. Stretch-activated cation channels (SA-Cat), or
mechanosensitive channels are a common type of cation entry in various
cells, which are exposed to mechanical stress. SA-Cat was reported to
be activated by cell swelling during the cell volume increase (31). In
this study, we have characterized the stretch-activated
Ca2+ entry pathways, which may represent SA-Cat activities
in both rat young osteocytes and in highly purified chicken osteocytes. By swelling the cells in hypo-osmotic solution, single cell
[Ca2+]i video-image analysis (25) visualized the
hypotonicity-induced [Ca2+]i increase, a common
feature of osteocytes in both species. Moreover, Ca2+
influx from the extracellular space explains the increased
[Ca2+]i by hypotonicity in most part, since the
increase was not observed in a Ca2+-free medium containing
EGTA. The Ca2+ influx was visualized in a single cell as
shown in Fig. 7. This is the first presentation of subcellular
Ca2+ distribution in osteocytes. Interestingly,
Ca2+ increase by hypotonic swelling was predominantly seen
in submembranous regions along the cell processes. A major event of
osteocytic differentiation from osteoblasts is the development of
extensive processes, which connect cell bodies between many osteocytes. Tanaka-Kamioka et al. (36) elegantly demonstrated that
processes of chicken osteocytes were organized primarily by actin
filaments. It has been suggested that cell processes connected through
gap junctions sense mechanical strain and/or fluid shear stress
resulting in the transmission of signals to neighboring osteocytes and
osteoblasts (37). Our subcellular Ca2+ imaging clearly
demonstrates a rapid Ca2+ influx, mainly along the cell
processes. When bathed in hypotonic solution, osteocytes rapidly swell
due to the influx of water through plasma membrane. Typically, mean
cell volume rapidly reaches a peak within 3 min and gradually
decreases. Such a time course of the regulatory volume changes is
similar to that of the [Ca2+]i increase that was
measured separately in single cells. In addition, the peak
[Ca2+]i increase caused by the hypotonic exposure
and measured in single cells on a glass coverslips paralleled the
increase in mean cell volume, which was measured in the cells suspended in the same hypotonic solution. All these data indicate that the Ca2+ influx pathway observed here is cell
volume-dependent and is possibly membrane
stretch-activated. The Ca2+ influx in turn, may activate
Ca2+-activated Cl channels as well as
Ca2+-activated K+ channels leading to the
decreased cell volume as reported in other cell types (31, 38). Under
the conditions employed, the [Ca2+]i increase was
detectable when the mean cell volume increased by 23% from the basal
volume. This result indicates that osteocytes are more sensitive than
endothelial cells, in which 20% elongation on silicon membrane caused
little change in [Ca2+]i (39). Osteocytes appear
to be extremely sensitive to mechanical strain since our previous study
of anabolic reaction showed that young osteocytes respond to low levels
of mechanical strain (up to 4,000 µE) to which osteoblasts do not
respond (5). It is quite likely that the development of extensive cell
processes, which is accompanied by differentiation of osteocytes,
allows these cells to acquire sensitivity to stretching by the SA-Cat concentrated along the processes, as we presented in this article.
Pharmacological studies to characterize the osteocyte SA-Cat using
different ion channel blockers revealed the following. Hypotonicity-induced Ca2+ influx in osteocytes, in most
part, is Gd3+-inhibitable but relatively insensitive to
blockers of VOCC, such as a dihydropyridine derivative, nitrendipine,
or verapamil, which are only effective at micromolar concentrations.
The overall pharmacological characteristics of this Ca2+
influx described here may be similar to that of UMR 106 cells (18, 40).
Since the molecular identity of the SA-Cat is uncertain, we can only
speculate on the nature of the protein from the properties of the
osteocyte Ca2+ influx pathways. Antisense
oligodeoxynucleotides (24- and 20-mer) against the 1C subunit of
UMR106 Ca2+ channel significantly inhibited hypotonic
increase of [Ca2+]i by 75-80% (Table I). In
contrast, antisense oligodeoxynucleotide (24-mer) against the 1D and
1S subunits of UMR106 Ca2+ channel had no significant
effects. These results suggest the common properties of SA-Cat to that
in UMR 106 osteoblast-like cells (18). Considering the fact that UMR
106 is a transformed cell line of heterogenous phenotype containing
cells at various stages of differentiation in the osteoblast lineage,
it is not surprising that they express SA-Cat of similar
characteristics. We have used the antisense oligodeoxynucleotides
against the region 5' of the S6 domain IV of 1C subunit of VOCC, and
we have clarified that the expression of 1C subunit of
Ca2+ channel is required for the function of
stretch-activated Ca2+ influx pathways in osteocytes. The
Ca2+ influx in osteocytes is sensitive to micromolar
concentration of dihydropyridine and that the depolarization of cell
membrane by high potassium solution (KCl 141 mM, NaCl 20 mM Ringer's solution) induced the
[Ca2+]i increase (70 ± 8 (S.E.)
(n = 6)) in 54.5% (6/11) cells examined. These
observations suggest either the heterogeneity of the population or that
the number of the molecules of 1C subunit of VOCC in osteocytes is
not large enough to create persistent [Ca2+]i
increases in response to membrane depolarization. In rat smooth muscle
cells, Langton (41) reported that a VOCC itself is activated by
membrane stretch. It is clear that 1C subunit of Ca2+
channel observed here has a pivotal role in the Ca2+ influx
in stretched osteocytes. Whether these 1C channels act as an SA-Cat
or that SA-Cat is an independent entity which is somehow regulated by
1C subunit of VOCC, however, remains to be answered.
We have found that PTH enhanced hypotonically stimulated
Ca2+ influx in osteocytes. The relationship between the
effects of PTH and mechanical loading has already been the subject of
many studies. Synergistic effects of mechanical stress and PTH on bone formation were reported in in vivo studies (13, 15). In
primary rat osteoblasts, Carvalho et al. (42) reported that
mechanical strain induced cAMP and IP3 increases and that
PTH augmented these effects. As described in the Introduction, PTH
potentiated stretch-activated cation channels in UMR 106 cells (16).
Recently, it was demonstrated by in situ hybridization that
PTH primed loading-induced c-fos mRNA expression in
osteocytes (13). They also demonstrated in rat bones that PTH injection
augmented osteogenic responses to mechanical loading. Moreover, no
osteogenic response was seen in thyroparathydectomized rats. Under the
conditions they tested, c-fos expression was detected only
in the osteocytes of those thyroparathydectomized rats that were
mechanically stimulated together with PTH administration. These results
suggest that PTH either sensitizes strain-sensing mechanism or is
involved in the downstream signaling. Our results showed that PTH
up-regulated strain sensing of osteocyte by enhancing Ca2+
influx resulting in up-regulation in the IGF-1 mRNA level. The presence of PTH receptors in osteocytes has been demonstrated recently
by in situ hybridization (14). In rat osteocytes,
hypotonicity-induced Ca2+ influx was enhanced by
pretreating cells with PTH in a dose-dependent manner
(Figs. 5 and 6). Subcellular Ca2+ imaging (Figs. 7 and 8)
suggested that PTH and hypotonic treatment stimulated
[Ca2+]i increase predominantly along the cell
processes. PTH receptors and stretch-activated Ca2+
channels are likely to be co-localized in the processes acting as a
mechanosensor. The PTH receptor is known to stimulate G protein-coupled cAMP production as well as phospholipase C activation (43). As shown in
Fig. 6, enhancement of hypotonicity-induced Ca2+ influx by
PTH was mimicked by dibutyryl cAMP, forskolin,
(Sp)-cAMP, a specific activator of protein
kinase A, and PTH-(1-31), a specific agonist that activates adenyl
cyclase but not phospholipase C (32). Neither PTH-(3-34), another
specific agonist that activates only the phospholipase C (33), nor TPA
which activates protein kinase C have stimulatory effect on the
[Ca2+]i increase. Moreover,
(Rp)-cAMP, a specific inhibitor of protein
kinase A, is inhibitory on the hypotonicity-induced [Ca2+]i increase. Thus, activation of adenylate
cyclase by PTH is required in its potentiation of hypotonicity-induced
[Ca2+]i increase. Besides PTH-(1-34),
PTHrp-(1-34) acted similarly, whereas C-terminal PTH-(35-84) was not
effective. The rapid increase in cAMP concentration in stretched rat
osteocytes (5) is likely representing the same mechanisms examined in
our study.
Further studies to delineate the molecular interaction between
PTH receptor and SA-Cat also necessitate molecular identification of
SA-Cat. Nevertheless, we clearly showed that PTH synergistically up-regulates IGF-1 mRNA levels in mechanically stretched rat young osteocytes. Our data indicate that the up-regulation of stretch-induced IGF-1 mRNA expression is mediated through the activation of
adenylate cyclase (Figs. 9 and 10). It should be noted that PTH
up-regulated osteogenic signals and that the response requires the
presence of extracellular Ca2+. Downstream reactions, which
connect Ca2+ to the regulatory element of IGF-1 and other
bone protein genes, are currently under investigation. Although other
factors than Ca2+ influx are certainly involved in the
expression of IGF-1 mRNA reducing the effect of Ca2+
channel blockers, the characteristics of inhibition of the
Ca2+ increase by Gd3+, nitrendipine, and 1C
antisense ODN (24-mer) are similar to those of the stretch-induced
IGF-1 mRNA elevation. These data suggest that the volume-sensitive
calcium influx described here is the initial event of
mechanotransduction leading to bone formation. Finally, we would like
to emphasize that osteocytes, especially their cell processes, are
furnished with volume-sensitive stretch-activated Ca2+
entry pathways that are intensified by PTH through the activation of
adenylate cyclase. The pathway is likely to be the essential component
of mechanosensing machinery that regulates bone formation.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Edward M. Greenfield (Department
of Orthopaedics, Case Western Reserve University) and Dr. Koji Okabe
(Department of Oral Physiology, Fukuoka Dental College) for critical
reading of this manuscript. We also thank Dr. Keith A. Hruska (Renal
Division, Barnes-Jewish Hospital at Washington University
Medical Center) and Dr. Yoshio Fujii (Calcium Research Institute) for
many helpful discussions.
 |
FOOTNOTES |
*
This work was supported by a health science research grant
(to A. M.) and Grants 8A-02 and 11C-02 for Collaborative Research of
Longevity Sciences from the Ministry of Health and Welfare of Japan (to
A. M.) and by a research grant from the Japanese Foundation of
Osteoporosis (to A. M.). This work was presented in part at the annual
meeting of the American Society for Bone and Mineral Research, December
1-6, 1998, San Francisco, CA.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
c
To whom correspondence should be addressed: National
Sanatorium Hyogo Chuo Hospital, 1314 Ohara, Sanda Hyogo 669-1515 Japan. Tel.: 01181-795-63-2121; Fax: 01181-78-992-8886; E-mail:
miyauchi@hyougotyu.hosp.go.jp.
 |
ABBREVIATIONS |
The abbreviations used are:
IGF-1, insulin-like
growth factor-1;
PTH, parathyroid hormone;
[Ca2+]i, cytosolic free calcium;
SA-Cat, stretch-activated cation channel;
Pipes, piperazine-N,N'-bis[2-ethanesulfonic acid];
TPA, 12-O-tetradecanoylphorbol- -acetate;
PTHrp, PTH-related protein;
VOCC, voltage-operated calcium channel;
RT-PCR, reverse transcriptase-polymerase chain reaction;
PBS, phosphate-buffered saline;
bp, base pairs;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
ODN, oligodeoxynucleotide.
 |
REFERENCES |
| 1.
|
Lanyon, L. E.
(1984)
Calcif. Tissue Int.
36,
S56-S61
|
| 2.
|
Tanaka, K.,
Matsuo, T.,
Ohta, M.,
Sato, T.,
Tezuka, K.,
Nijweide, P. J.,
Katoh, Y.,
Hakeda, Y.,
and Kumegawa, M.
(1995)
Miner. Electrolyte Metab.
21,
189-192[Medline]
[Order article via Infotrieve]
|
| 3.
|
Maejima-Ikeda, A.,
Aoki, M.,
Tsuritani, K.,
Kamioka, K.,
Hiura, K.,
Miyoshi, T.,
Hara, H.,
Takano-Yamamoto, T.,
and Kumegawa, M.
(1997)
Biochem. J.
322,
245-250
|
| 4.
|
Lean, J. M.,
Jagger, C. J.,
Chambers, T. J.,
and Chow, J. W.
(1995)
Am. J. Physiol.
268,
E318-E327[Abstract/Free Full Text]
|
| 5.
|
Mikuni-Takagaki, Y.,
Suzuki, Y.,
Kawase, T.,
and Saito, S.
(1996)
Endocrinology
137,
2028-2035[Abstract]
|
| 6.
|
Klein-Nulend, J.,
Van der Plas, A.,
Semeins, C. M.,
Ajubi, N. E.,
Frangos, J. A.,
Nijweide, P. J.,
and Burger, E. H.
(1995)
FASEB J.
9,
441-445[Abstract/Free Full Text]
|
| 7.
|
Ajubi, N. E.,
Klein-Nulend, J.,
Nijweide, P. J.,
Vrijheid-Lammers, T.,
Alblas, M. J.,
and Burger, E. H.
(1996)
Biochem. Biophys. Res. Commun.
225,
62-68[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Kawata, A.,
and Mikuni-Takagaki, Y.
(1998)
Biochem. Biophys. Res. Commun.
246,
404-408[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Klein-Nulend, J.,
Burger, E. H.,
Semeins, C. M.,
Raisz, L. G.,
and Pilbeam, C. C.
(1997)
J. Bone Miner. Res.
12,
45-51[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Klein-Nulend, J.,
Semeins, C. M.,
Ajubi, N. E.,
Nijweide, P. J.,
and Burger, E. H.
(1995)
Biochem. Biophys. Res. Commun.
271,
640-648
|
| 11.
|
Inaoka, T.,
Lean, J. M.,
Bessho, T.,
Chow, J. W. M.,
Mackay, A.,
Kokubo, T.,
and Chambers, T. J.
(1995)
Biochem. Biophys. Res. Commun.
217,
264-270[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Lean, J. M.,
Mackay, A. G.,
Chow, J. W. M.,
and Chambers, T. J.
(1996)
Am. J. Physiol.
270,
E937-E945
|
| 13.
|
Chow, J. W. M.,
Fox, S.,
Jagger, C. J.,
and Chambers, T. J.
(1998)
Am. J. Physiol.
274,
E146-E154[Abstract/Free Full Text]
|
| 14.
|
Fermor, B.,
and Skerry, T. M.
(1995)
J. Bone. Miner. Res.
10,
1935-1943[Medline]
[Order article via Infotrieve]
|
| 15.
|
Ma, Y.,
Jee, W. S. S.,
Yuan, Z.,
Wei, W.,
Chen, H.,
Pun, S.,
Liang, H.,
and Lin, C
(1999)
J. Bone. Miner. Res.
14,
439-448[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Duncan, R. L.,
Hruska, K. A.,
and Misler, S.
(1992)
FEBS Lett.
307,
219-223[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Duncan, R. L.,
and Hruska, K. A.
(1994)
Am. J. Physiol.
267,
F909-F916[Abstract/Free Full Text]
|
| 18.
|
Duncan, R. L.,
Kizer, N.,
Barry, E. L. R.,
Friedman, P. A.,
and Hruska, K. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1864-1869[Abstract/Free Full Text]
|
| 19.
|
Van der Plas, A.,
and Nijweide, P. J.
(1992)
J. Bone Miner. Res.
7,
389-396[Medline]
[Order article via Infotrieve]
|
| 20.
|
Mikuni-Takagaki, Y.,
Kakai, Y.,
Satoyoshi, M.,
Kawano, E.,
Suzuki, Y.,
Kawase, T.,
and Saito, S.
(1995)
J. Bone Miner. Res.
10,
231-242[Medline]
[Order article via Infotrieve]
|
| 21.
|
Hazama, A.,
and Okada, Y.
(1988)
J. Physiol. (Lond.)
402,
687-702[Abstract/Free Full Text]
|
| 22.
|
Okada, Y.,
Hazama, A.,
and Yuan, W. L.
(1990)
Neurosci. Res.
12 (suppl.),
5-13
|
| 23.
|
Miyauchi, A.,
Hruska, K. A.,
Greenfield, E. M.,
Duncan, R.,
Alvarez, J.,
Barattolo, R.,
Colucci, S.,
Zambonin-Zallone, A.,
Teitelbaum, S. L.,
and Teti, A.
(1990)
J. Cell Biol.
111,
2543-2552[Abstract/Free Full Text]
|
| 24.
|
Miyauchi, A.,
Alvarez, J.,
Greenfield, E. M.,
Teti, A.,
Grano, M.,
Colucci, S.,
Zambonin-Zallone, A.,
Ross, F. P.,
Teitelbaum, S. L.,
Cheresh, D.,
and Hruska, K. A.
(1991)
J. Biol. Chem.
266,
20369-20374[Abstract/Free Full Text]
|
| 25.
|
Miyauchi, A.,
Notoya, K.,
Taketomi, S.,
Takagi, Y.,
Fujii, Y.,
Jinnai, K.,
Takahashi, K.,
Chihara, K.,
and Fujita, T.
(1996)
Endocrinology
137,
3544-3550[Abstract]
|
| 26.
|
Kudo, Y.,
and Ogura, A.
(1986)
Br. J. Pharmacol.
89,
191-198[Medline]
[Order article via Infotrieve]
|
| 27.
|
Ogura, A.,
Nakazawa, M.,
and Kudo, Y.
(1992)
Neurosci. Res.
12,
606-616[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Barry, E. L. R.,
Gesek, F. A.,
Froehner, S. C.,
and Friedman, P. A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10914-10918[Abstract/Free Full Text]
|
| 29.
|
Meszaros, J. G.,
Karin, N. J.,
Akanbi, K.,
and Farach-Carson, M. C.
(1996)
J. Biol. Chem.
271,
32981-32985[Abstract/Free Full Text]
|
| 30.
|
Takemura, H.,
Hughes, A. R.,
Thastrup, O.,
and Putney, J. W., Jr.
(1989)
J. Biol. Chem.
264,
12266-12271[Abstract/Free Full Text]
|
| 31.
|
Hamill, O. P.,
and Mcbride, D. W., Jr.
(1996)
Pharmacol. Rev.
48,
231-248[Abstract]
|
| 32.
|
Rixon, R. H.,
Whitfield, J. F.,
Gagnon, L.,
Isaacs, R. J.,
Maclean, S.,
Chakravarthy, B.,
Durkin, J. P.,
Neugebauer, W.,
Ross, V.,
Sung, W.,
and Willick, G. E.
(1994)
J. Bone Miner. Res.
9,
1179-1189[Medline]
[Order article via Infotrieve]
|
| 33.
|
Fujimori, A.,
Cheng, S. L.,
Avioli, L. V.,
and Civitelli, R.
(1991)
Endocrinology
128,
3032-3039[Abstract/Free Full Text]
|
| 34.
|
Scheinman, S. J.,
Stec, W. J.,
and Coulson, R.
(1985)
Miner. Electrolyte Metab.
11,
85-90[Medline]
[Order article via Infotrieve]
|
| 35.
|
Erneux, C.,
Van Sandle, J.,
Jastorff, B.,
and Dumont, J.
(1986)
Biochem. J.
234,
193-197[Medline]
[Order article via Infotrieve]
|
| 36.
|
Tanaka-Kamioka, K.,
Kamioka, H.,
Ris, H.,
and Lim, S. S.
(1998)
J. Bone Miner. Res.
13,
1555-1568[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Lanyon, L. E.
(1993)
Calcif. Tissue Int.
53 Suppl. 1,
102-107[CrossRef]
|
| 38.
|
McCarty, N. A.,
and O'Neil, R.
(1992)
Physiol. Rev.
72,
1037-1056[Abstract/Free Full Text]
|
| 39.
|
Naruse, K.,
and Sokabe, M.
(1993)
Am. J. Physiol.
264,
C1037-C1044[Abstract/Free Full Text]
|
| 40.
|
Yamaguchi, D. T.,
Green, J.,
Kleeman, C. R.,
and Muallem, S.
(1988)
J. Biol. Chem.
264,
4383-4390[Abstract/Free Full Text]
|
| 41.
|
Langton, P. D.
(1993)
J. Physiol. (Lond.)
471,
1-11[Abstract/Free Full Text]
|
| 42.
|
Carvalho, R. S.,
Scott, J. E.,
Suga, D. M.,
and Yen, E. H. K.
(1994)
J. Bone Miner. Res.
9,
999-1011[Medline]
[Order article via Infotrieve]
|
| 43.
|
Abou-Samra, A. B.,
Juppner, H.,
Force, T.,
Freeman, M. W.,
Kong, Z. F.,
Schipani, E.,
Urena, P.,
Richards, J.,
Bonventre, J. V.,
Potts, J. T.,
Kronenberg, H. M.,
and Segre, G. V.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
2732-2736[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. F. Morgan, R. E. Gleason, L. N. M. Hayward, P. L. Leong, and K. T. S. Palomares
Mechanotransduction and Fracture Repair
J. Bone Joint Surg. Am.,
February 1, 2008;
90(Supplement_1):
25 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, L. M. McNamara, M. B. Schaffler, and S. Weinbaum
A model for the role of integrins in flow induced mechanotransduction in osteocytes
PNAS,
October 2, 2007;
104(40):
15941 - 15946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Holmbeck, P. Bianco, I. Pidoux, S. Inoue, R. C. Billinghurst, W. Wu, K. Chrysovergis, S. Yamada, H. Birkedal-Hansen, and A. R. Poole
The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone
J. Cell Sci.,
January 1, 2005;
118(1):
147 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Turner and A. G. Robling
Mechanical Loading and Bone Formation
IBMS BoneKEy,
September 1, 2004;
1(9):
15 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Boutahar, A. Guignandon, L. Vico, and M.-H. Lafage-Proust
Mechanical Strain on Osteoblasts Activates Autophosphorylation of Focal Adhesion Kinase and Proline-rich Tyrosine Kinase 2 Tyrosine Sites Involved in ERK Activation
J. Biol. Chem.,
July 16, 2004;
279(29):
30588 - 30599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kumar, A. J. Knox, and A. M. Boriek
CCAAT/Enhancer-binding Protein and Activator Protein-1 Transcription Factors Regulate the Expression of Interleukin-8 through the Mitogen-activated Protein Kinase Pathways in Response to Mechanical Stretch of Human Airway Smooth Muscle Cells
J. Biol. Chem.,
May 23, 2003;
278(21):
18868 - 18876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, R. L. Duncan, D. B. Burr, V. H. Gattone, and C. H. Turner
Parathyroid Hormone Enhances Mechanically Induced Bone Formation, Possibly Involving L-Type Voltage-Sensitive Calcium Channels
Endocrinology,
April 1, 2003;
144(4):
1226 - 1233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kojima, A. Nemoto, T. Uemura, R. Honma, M. Ogura, and Y.-k. Liu
rDRAK1, a Novel Kinase Related to Apoptosis, Is Strongly Expressed in Active Osteoclasts and Induces Apoptosis
J. Biol. Chem.,
May 25, 2001;
276(22):
19238 - 19243.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|